Après délibération, le collège de la Haute Autorité de santé, en sa séance du 17 décembre 2020 a constaté l’absence d’évaluation médico-économique du produit COREVALVE EVOLUT R & EVOLUT PRO sur les dépenses de l’assurance maladie.
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
sqAnratJhb2pYmsr
